DRG^® International, Inc., is committed to providing the medical and research community with cutting edge, easy-to-use and effective diagnostic equipment. Founded in 1970, DRG International is constantly looking towards the future in order to continue to produce and distribute the highest-quality products.
With the DRG International name behind our products, you can expect they will be expertly researched, designed and manufactured.
DRG is proud to provide diagnostic equipment to over 110 countries all over the world.
Come by our booth #3713 at AACC 2016!

Featured Products:

Hepcidin 25 (bioactive) HS
Catalog Number = EIA5782

DRG International, Inc. is proud to introduce the Hepcidin 25 (bioactive) HS ELISA. This improved High Sensitive Hepcidin assay boasts an analytical sensitivity of 0.153 ng/mL and a measuring range of 0.153-81 ng/mL. The assay also features a friendlier user protocol with the ability to assess both serum and plasma, ready to use calibrators, no shaking or assay buffer requirements, and a total incubation time of less than two hours. DRG International, Inc. holds 21 U.S. and International Hepcidin patents.

DRG:Hybrid XL
This innovative and unique technology allows, for the first time, the simultaneous measurement of immunoassays and clinical chemistry parameters in one sample.
The lab top analyzer, ideal for medium-sized and small laboratories, provides diagnostic services to hospitals, clinics and large medical practice facilities.
Up to 40 tests and up to 20-patient samples can be measured in custom panels by the medical practitioner over a wide range of pre-packaged tests to serve different specialties.